N-Formyl leurosine
CAS: 54022-49-0
Ref. 3D-IF23552
1mg | To inquire | ||
2mg | To inquire | ||
5mg | To inquire | ||
10mg | To inquire |
Product Information
- (3'a,4'a)-4'-Deoxy-3',4'-epoxy-22-oxovincaleukoblastineVincristine impurity G
- (2alpha,2'beta,3alpha,3'beta,4alpha,5beta,19beta)-22-oxo-O~3~',3'-cyclovincaleukoblastine
- 1H-Indolizino[8,1-cd]carbazole, vincaleukoblastine deriv.
- 22-Oxoleurosine
- 22-oxo-O~3~',3'-cyclovincaleukoblastine
- 2H-3,13-Methanooxireno[9,10]azacycloundecino[5,4-b]indole, vincaleukoblastine deriv.
- 4'-Desoxy-3'alpha,4'alpha-epoxyvincristin
- F-Leurosine
- Formyl-leurosine
- Formylleurosine
- See more synonyms
- Leuroformine
- N-Demethyl-N-formylleurosine
- N-Formyl N-demethylleurosine
- N-Formylleurosine
- Nsc 269419
- Unii-I4U9Nzs9T5
- Vincaleukoblastine, 4'-deoxy-3',4'-epoxy-22-oxo-, (3'-alpha,4'-alpha)- (9CI)
- Vincaleukoblastine, 4′-deoxy-3′,4′-epoxy-22-oxo-, (3′α,4′α)-
- Vinformida
- Vinformida [INN-Spanish]
- Vinformide
- Vinformide [INN]
- Vinformidum
- Vinformidum [INN-Latin]
- f-Leu
N-Formyl leurosine is an inhibitor of fatty acid synthesis. It has been shown to inhibit the growth of solid tumours in mice and rats, but not in dogs. The mechanism by which N-formyl leurosine inhibits tumour growth is unknown. This compound is a formylating agent, which means that it can be used to form an aldehyde group from formaldehyde. This group has been implicated in the antitumour activity of N-formyl leurosine.
Chemical properties
Technical inquiry about: 3D-IF23552 N-Formyl leurosine
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.